S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NASDAQ:AZN

AstraZeneca - AZN Earnings Date, Estimates & Call Transcripts

$66.74
+1.13 (+1.72%)
(As of 03/20/2023 05:30 PM ET)
Add
Compare
Today's Range
$65.79
▼
$66.77
50-Day Range
$63.15
▼
$71.60
52-Week Range
$52.65
▼
$72.12
Volume
3.99 million shs
Average Volume
5.30 million shs
Market Capitalization
$206.87 billion
P/E Ratio
62.37
Dividend Yield
2.89%
Price Target
$126.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AZN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AZN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AstraZeneca Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$0.82$0.82$0.82 
Q2 20231$0.83$0.83$0.83 
Q3 20231$0.96$0.96$0.96 
Q4 20231$1.14$1.14$1.14 
FY 20234$3.75$3.75 $3.75

AZN Earnings Date and Information

AstraZeneca has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 5th, 2023 based off prior year's report dates.

AstraZeneca Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/5/2023
(Estimated)		        
11/10/2022Q3 2022$0.77$0.84+$0.07$1.15$10.98 billion$10.98 billion
7/29/2022Q2 2022$0.78$0.86+$0.08$1.60$10.44 billion$10.77 billion
4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$11.19 billion$11.39 billion    
4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$10.96 billion$11.39 billion  
2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.04 billion$12.01 billion
2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.06 billion$11.50 billion  
11/12/2021Q3 2021$0.63$0.54($0.09)$1.63$9.82 billion$9.87 billion
11/11/20219/30/2021$0.62$0.54($0.08)$1.63$9.58 billion$9.74 billion    
7/29/2021Q2 2021$0.45$0.45$0.69$7.79 billion$8.22 billion
7/28/20216/30/2021$0.43$0.45+$0.02$0.69$7.79 billion$8.22 billion    
4/30/2021Q1 2021$0.71$0.81+$0.10$1.03$7.17 billion$7.32 billion
4/29/20213/31/2021$0.71$0.82+$0.11$1.03$7.15 billion$7.32 billion  
2/11/2021Q4 2020$0.53$0.54+$0.01$0.69$6.98 billion$7.41 billion
2/10/202112/31/2020$0.68$0.54($0.14)$0.69$6.98 billion$7.41 billion  
11/10/20209/30/2020$0.44$0.47+$0.03$0.69$6.65 billion$6.58 billion  
11/5/2020Q3 2020$0.49$0.47($0.02)$0.69$6.54 billion$6.58 billion
11/5/2020Q3 2020$0.49$0.47($0.02)$0.69$6.54 billion$6.58 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.25 billion$6.28 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.25 billion$6.28 billion
7/30/20206/30/2020$0.44$0.48+$0.04$0.67$6.27 billion$6.28 billion  
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.81 billion$6.35 billion
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.81 billion$6.35 billion
4/29/20203/31/2020$0.47$0.53+$0.06$0.76$5.95 billion$6.35 billion  
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.71 billion$6.66 billion
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.71 billion$6.66 billion
2/14/202012/31/2019$0.53$0.45($0.08)$0.78$6.75 billion$6.66 billion  
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.14 billion$6.41 billion
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.14 billion$6.41 billion
10/24/20199/30/2019$0.45$0.50+$0.05$0.88$6.07 billion$6.13 billion  
7/25/2019Q2 2019$0.32$0.37+$0.05$0.69$5.51 billion$5.82 billion
7/25/2019Q2 2019$0.32$0.37+$0.05$0.69$5.51 billion$5.82 billion
7/25/20196/30/2019$0.30$0.73+$0.43$1.37$5.57 billion$5.72 billion  
4/26/2019Q1 2019$0.43$0.45+$0.02$0.66$5.27 billion$5.49 billion
4/26/2019Q1 2019$0.43$0.45+$0.02$0.66$5.27 billion$5.49 billion
4/26/20193/31/2019$0.43$0.45+$0.02$0.66$5.40 billion$5.47 billion  
2/14/2019Q4 2018$0.73$0.79+$0.06$1.17$6.16 billion$6.42 billion
2/14/2019Q4 2018$0.73$0.79+$0.06$1.17$6.16 billion$6.42 billion
2/14/201912/31/2018$0.73$1.58+$0.85$2.34$6.33 billion$6.42 billion  
11/8/2018Q3 2018$0.33$0.36+$0.03$0.55$5.12 billion$5.34 billion
11/8/2018Q3 2018$0.33$0.36+$0.03$0.55$5.12 billion$5.34 billion
11/8/20189/30/2018$0.33$0.71+$0.38$1.08$5.26 billion$5.34 billion  
7/26/2018Q2 2018$0.31$0.35+$0.04$0.56$4.99 billion$5.16 billion
7/26/2018Q2 2018$0.31$0.35+$0.04$0.56$4.99 billion$5.16 billion
7/26/20186/30/2018$0.31$0.69+$0.38$1.11$5.09 billion$5.16 billion  
5/18/2018Q1 2018$0.28$0.24($0.04)$0.35$5.34 billion$5.18 billion
5/18/2018Q1 2018$0.28$0.24($0.04)$0.35$5.34 billion$5.18 billion
5/18/20183/31/2018$0.28$0.48+$0.20$0.69$5.24 billion$5.18 billion  
2/2/2018Q4 2017$0.45$0.65+$0.20$0.78$5.59 billion$5.78 billion
2/2/2018Q4 2017$0.45$0.65+$0.20$0.78$5.59 billion$5.78 billion
2/2/2018Q4 2017$0.44$1.30+$0.86$1.57$5.49 billion$5.78 billion  
11/9/2017Q3 2017$0.57$0.56($0.01)$0.85$5.75 billion$6.23 billion
11/9/2017Q3 2017$0.57$0.56($0.01)$0.85$5.75 billion$6.23 billion
11/9/2017Q3$0.57$1.12+$0.55$1.70$6.00 billion$6.23 billion
7/27/2017Q2 2017$0.41$0.44+$0.03$0.69$5.05 billion$5.05 billion
7/27/2017Q2 2017$0.41$0.44+$0.03$0.69$5.05 billion$5.05 billion
7/27/20176/30/2017$0.41$0.87+$0.46$1.36$5.04 billion$5.05 billion
4/27/2017Q1 2017$0.38$0.50+$0.12$0.79$5.41 billion$5.41 billion
4/27/2017Q1 2017$0.38$0.50+$0.12$0.79$5.41 billion$5.41 billion
4/27/20173/31/2017$0.38$0.99+$0.61$1.56$5.40 billion$5.41 billion
2/2/2017Q4 2016$0.51$0.61+$0.10$0.49$5.61 billion$5.59 billion
2/2/2017Q4 2016$0.51$0.61+$0.10$0.49$5.61 billion$5.59 billion
2/2/2017Q416$0.51$1.21+$0.70$0.97$5.43 billion$5.59 billion  
11/10/2016Q3 2016$0.48$0.66+$0.18$0.92$5.95 billion$5.70 billion
11/10/2016Q3 2016$0.48$0.66+$0.18$0.92$5.95 billion$5.70 billion
11/10/2016Q316$0.48$1.32+$0.84$1.84$5.95 billion$5.70 billion
7/28/2016Q2 2016$0.42$0.42$0.84$5.58 billion$5.60 billion
7/28/2016Q2 2016$0.42$0.42$0.84$5.58 billion$5.60 billion
7/28/2016Q216$0.76$0.83+$0.07$1.66$5.56 billion$5.60 billion  
4/29/2016Q1 2016$0.60$0.48($0.12)$0.70$5.90 billion$6.12 billion
4/29/2016Q1 2016$0.60$0.48($0.12)$0.70$5.90 billion$6.12 billion
4/29/2016Q1$0.5970$0.51($0.0870)$1.39$5.96 billion$6.12 billion  
2/4/2016Q4 2015$0.88$0.47($0.41)$0.62$6.19 billion$6.40 billion
2/4/2016Q4 2015$0.88$0.47($0.41)$0.62$6.19 billion$6.40 billion
2/4/2016Q415$0.88$0.94+$0.06$1.26$6.27 billion$6.40 billion
11/5/2015Q3 2015$0.51$0.51$0.72$5.93 billion$5.95 billion
11/5/2015Q3 2015$0.51$0.51$0.72$5.93 billion$5.95 billion
11/5/2015Q315$0.51$1.03+$0.52$1.45$5.90 billion$5.85 billion
7/30/2015Q2 2015$0.52$0.61+$0.09$0.94$6.10 billion$6.31 billion
7/30/2015Q2 2015$0.52$0.61+$0.09$0.94$6.10 billion$6.31 billion
7/30/2015Q2$0.52$1.21+$0.69$1.87$6.02 billion$5.84 billion  
4/24/2015Q1 2015$0.54$0.54$0.86$5.93 billion$6.06 billion
4/24/2015Q1 2015$0.54$0.54$0.86$5.93 billion$6.06 billion
4/24/2015Q1$1.07$1.08+$0.01$0.86$5.87 billion$6.06 billion
2/5/2015Q4 2014$0.42$0.38($0.04)$0.89$6.70 billion$6.68 billion
2/5/2015Q4 2014$0.42$0.38($0.04)$0.89$6.70 billion$6.68 billion
2/5/2015Q314$0.85$0.76($0.09)$0.89$6.68 billion$6.68 billion
11/6/2014Q3 2014$0.52$0.53+$0.01$0.96$6.35 billion$6.54 billion
11/6/2014Q3 2014$0.52$0.53+$0.01$0.96$6.35 billion$6.54 billion
11/6/2014Q3$1.04$1.05+$0.01$0.96$6.44 billion$6.54 billion
7/31/2014Q2 2014$0.57$0.65+$0.08$0.98$6.18 billion$6.45 billion
7/31/2014Q2 2014$0.57$0.65+$0.08$0.98$6.18 billion$6.45 billion
7/31/2014Q214$1.09$1.30+$0.21$0.98$6.24 billion$6.45 billion  
4/29/2014Q1 2014$0.60$0.59($0.01)$0.98$6.28 billion$6.42 billion
4/29/2014Q1 2014$0.60$0.59($0.01)$0.98$6.28 billion$6.42 billion
4/29/2014Q114$1.23$1.17($0.06)$0.98$6.32 billion$6.42 billion  
2/6/2014Q4 2013$0.64$0.62($0.02)$1.45$6.94 billion$6.84 billion
2/6/2014Q4 2013$0.64$0.62($0.02)$1.45$6.94 billion$6.84 billion
2/6/2014Q4 2013$0.64$0.62($0.02)$1.45$6.91 billion$3.84 billion
10/31/2013Q3 2013$0.64$0.61($0.03)$0.72$6.45 billion$6.25 billion
10/31/2013Q3 2013$0.64$0.61($0.03)$0.72$6.45 billion$6.25 billion
10/31/2013Q3 2013$0.64$0.61($0.03)$0.72$6.45 billion$6.25 billion  
8/1/2013Q2 2013$0.59$0.60+$0.01$0.87$6.24 billion$6.23 billion
8/1/2013Q2 2013$0.59$0.60+$0.01$0.87$6.24 billion$6.23 billion
8/1/2013Q2 2013$0.59$0.60+$0.01$0.87$6.24 billion$6.23 billion  
4/25/2013Q1 2013$0.67$0.71+$0.04$1.01$6.50 billion$6.39 billion
4/25/2013Q1 2013$0.67$0.71+$0.04$1.01$6.50 billion$6.39 billion
4/25/2013Q1 2013$0.67$0.71+$0.04$1.01$6.54 billion$6.39 billion  
1/31/2013Q412$1.37$1.56+$0.19$7.17 billion$7.28 billion  
10/25/2012$1.44$1.51+$0.07  
7/26/2012$1.38$1.53+$0.15  
4/26/2012$1.73$1.81+$0.08
2/2/2012$1.57$1.61+$0.04
10/27/2011$1.64$1.71+$0.07
7/28/2011$1.74$1.53($0.21)
4/27/2011Q1 2011$1.02$1.04+$0.02$1.04
1/27/2011Q4 2010$0.67$0.68+$0.01$0.79
10/27/2010Q3 2010$0.76$0.54($0.22)$0.54
7/30/2010Q2 2010$0.80$0.73($0.07)$0.73
4/29/2010Q1 2010$0.86$1.02+$0.16$1.08
10/29/2009Q3 2009$0.68$0.73+$0.05$0.73
7/30/2009Q2 2009$0.68$0.82+$0.14$1.05
1/29/2009Q4 2008$0.59$0.63+$0.04$0.83
4/24/2008Q1 2008$0.60$0.52($0.08)$0.52
1/31/2008Q4 2007$0.50$0.52+$0.02$0.61












AstraZeneca Earnings - Frequently Asked Questions

When is AstraZeneca's earnings date?

AstraZeneca has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 5th, 2023 based off last year's report dates. Learn more on AZN's earnings history.

How much revenue does AstraZeneca generate each year?

AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $44.35 billion.

How much profit does AstraZeneca generate each year?

AstraZeneca (NASDAQ:AZN) has a recorded net income of $3.29 billion. AZN has generated $1.07 earnings per share over the last four quarters.

What is AstraZeneca's price-to-earnings ratio?

AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 62.32 and a forward price-to-earnings ratio of 18.47. The price/earnings-to-growth ratio is 1.2.

What is AstraZeneca's EPS forecast for next year?

AstraZeneca's earnings are expected to grow from $3.61 per share to $4.20 per share in the next year, which is a 16.34% increase.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:AZN) was last updated on 3/20/2023 by MarketBeat.com Staff